Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Gray Sheet

Executive Summary

President/COO Greg Cash will assume CEO position as of June 30, replacing Fred Paulson, who will remain a board member. Cash also will serve on the board...

You may also be interested in...

People In Brief

Orthofix elects new chairman: Eight-year board member Jim Gero to become orthopedic firm's new chair, replacing Robert Gaines-Cooper by year-end, the company announces March 26. Gero formerly served as director of American Medical Electronics, which Orthofix acquired in 1995, and as CEO of Sierra Technologies and Sierra Networks. Gaines-Cooper will remain a non-executive director while undertaking other entrepreneurial ventures, Orthofix notes. He plans to divest about 70% of his trust over the next 18 months, which is made up of 1.3 mil. Orthofix shares...

E.l.f. Has A Go At Twitch Crowd, Hitching Wagon To #Loserfruit

The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.

An Oversupply Of COVID Antibody Treatments? Multiple Monoclonal Products Raise Potential For Errors

As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts